Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Article(3)
Publisher
Breast Cancer: Basic and Clinical Research(1)
Cancer Biology and Therapy(1)
Clinical Cancer Research(1)
1E10 anti-idiotype vaccine in non-small cell lung cancer: Experience in stage IIIb/IV patients
ArticleAbstract: Conventional treatment of non-small cell lung cancer (NSCLC) has apparently reached a plateau of effPalabras claves:Anti-idiotype antibody, Cancer Vaccines, Clinical study, immunotherapyAutores:Aguirre F., Alfonso S., Alonso D.F., Barroso M.C., Carmen Elena Viada, De La Torre A.V., Díaz R.M., Gabri M.R., Gómez R., Hernández A.M., Macías A.E., Pérez K., Pérez R., Rodríguez J., Santiesteban E.R., Suárez E., Toledo D., Vázquez A.M.Fuentes:scopusA randomized, multicenter, placebo-controlled clinical trial of racotumomab-alum vaccine as switch maintenance therapy in advanced non-small cell lung cancer patients
ArticleAbstract: Purpose: Racotumomab-alum is an anti-idiotype vaccine targeting the NeuGcGM3 tumor-associated gangliPalabras claves:Autores:Alfonso S., Areces F., Carmen Elena Viada, Cepeda M., Chong E., De La Torre A.V., Flores Y.I., García E., Gonzalez Z., Guerra P.P., Hernández A.M., Hernández M., Macías A.E., Mazorra Z., Mendoza I.C., Ortiz R.A., Pérez K., Pérez R., Santiesteban E.R., Tania Crombet, Toledo D., Valdes-Zayas A., Vázquez A.M.Fuentes:scopusNGlycolylGM3/VSSP vaccine in metastatic breast cancer patients: Results of phase I/IIa clinical trial
ArticleAbstract: Patients treated with vaccines based on NGlycolil gangliosides have showed benefit in progression frPalabras claves:Clinical trial, Ganglioside, Metastatic breast cancer, NGcGM3, Therapeutic vaccineAutores:Arboláez M., Car A., Carmen Elena Viada, Cepeda M., De La Torre A.V., Fernandez L.E., García E., Guerra P.P., Hernandez J., Ortiz R.A., Pérez K., Toledo D.Fuentes:scopus